Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 2
2006 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 5
2014 3
2015 3
2016 4
2017 2
2018 5
2019 4
2020 6
2021 6
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers.
Goyal V, Krantz E, Simon F, Neven A, Eriksson J, Saayman A, Ibnou Zekri Lassout N, Louis M, Robinson S, Deshmukh A, Antarkar A, Ruffell C, Victor S, Chenel M, Celebic A, Caplain H, Gillon JY, Ribeiro I. Goyal V, et al. Among authors: chenel m. Clin Transl Sci. 2024 Mar;17(3):e13756. doi: 10.1111/cts.13756. Clin Transl Sci. 2024. PMID: 38488418 Free PMC article. Clinical Trial.
Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia.
Derippe T, Fouliard S, Marchiq I, Dupouy S, Almena-Carrasco M, Geronimi J, Declèves X, Chenel M, Mager DE. Derippe T, et al. Among authors: chenel m. Cancer Res Commun. 2022 Nov 30;2(11):1532-1544. doi: 10.1158/2767-9764.CRC-22-0176. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970053 Free PMC article.
Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.
Tosca EM, Gauderat G, Fouliard S, Burbridge M, Chenel M, Magni P. Tosca EM, et al. Among authors: chenel m. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1396-1411. doi: 10.1002/psp4.12710. Epub 2021 Oct 28. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34708556 Free PMC article.
49 results